FDA Inspection
VitalantVitalant – FDA Inspection, Jan 23, 2014
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on January 23, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Vitalant
- Inspection Date
- January 23, 2014
- Product Type
- Biologics
View Company Profile
ID · 741d77f0-005a-44e3-acde-0f1eca52a1ae
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 863337
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
7| Date | Classification | Office | Project area |
|---|---|---|---|
| January 23, 2025 | NAI | Blood and Blood Products | |
| May 6, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 29, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 25, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 3, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1260496 - 2025-01-23
- FDA Inspection 1169573 - 2022-05-06
- FDA Inspection 1060236 - 2018-06-29
- FDA Inspection 989063 - 2016-08-25
- FDA Inspection 809259 - 2012-02-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.